Psychiatry & Neurology Doctors in Centreville, VA Accepting Medicare

4 Psychiatry & Neurology doctors found. Showing 1 - 4

Sheela Kadekar, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 5675 Stone Rd, Suite 320, Centreville, VA 20120 Phone: 703-402-2513    Fax: 703-830-0001

Mr. Young Hoon Bae, MD Psychiatry & Neurology - Psychiatry Medicare: May Accept Medicare Assignments Practice Location: 14631 Lee Hwy Ste 214, Centreville, VA 20121 Phone: 703-830-1800    Fax: 703-830-1801

Dr. Sarah Elizabeth Iannucci, D.O. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 14631 Lee Hwy, Suite 207, Centreville, VA 20121 Phone: 571-839-3628

Dr. Ira Clifford Newman, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 14631 Lee Hwy, Suite #207, Centreville, VA 20121 Phone: 703-830-0754

News Archive

High GI diet's make fatty liver epidemic a very real threat

According to a recent study, following a high Glycemic Index (GI) diet may increase a persons risk of fatty liver disease.

Consumption of ultra-processed foods and drinks could raise colorectal cancer risk

Consumption of ultra-processed foods and drink could increase the risk of developing colorectal cancer. This was the conclusion of a large study undertaken by the Barcelona Institute for Global Health, a center supported by the "la Caixa" Foundation, based on questionnaires about food behaviors completed by around 8,000 people in Spain.

Benitec strengthens patent position in RNAi

Benitec Limited (ASX: BLT), (PINK:BNIKF), a world leader in expressed gene silencing for human therapeutics, is pleased to announce that the United States Patent and Trademark Office (USPTO) has today indicated that it is issuing the Re-examination Certificate, the formal final step in the USPTO's confirmation of patentability of claims in the key ‘099 Graham Patent [US Patent No. 6,573,099] "Genetic Constructs for Delaying or Repressing the Expression of a Target Gene", the wide-ranging platform technology patent covering the use of expressed RNA interference (RNAi) in human therapeutic applications.

FDA grants Perrigo final approval for Guaifenesin Extended-Release Tablets ANDA

Perrigo Company today announced that it received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Guaifenesin Extended-Release Tablets, 600 mg.

Certain aquatic insects can forewarn against possible outbreaks of diarrheal disease, shows study

Chironomids, a group of aquatic insects closely related to mosquitoes, act as natural reservoirs of disease-causing cholera bacteria and can forewarn against possible outbreaks of the diarrhoeal disease, a new study suggests

Read more Medical News

› Verified 5 days ago